Is 4-AcO-DMT legal in Turkey?

Legal status

4-AcO-DMT is not confirmed as a controlled substance in Turkey and this row is a deferral rather than a finding. The dossier searched the Turkish terms «4-AcO-DMT» and «psiloasetİN» and the transliterations 4-AcO-DMT and psiloasetin against the classification decisions made under article 19 of Law No. 2313 on the Control of Narcotic Substances, and confirmed no current entry. It rejected the near match «psilosibin», because the acetate ester is not psilocybin. That rejection is the pivot of the row. Psilocybin is verified as scheduled on its own row, 4-AcO-DMT is its acetate ester and is metabolised to the same active compound, and Turkish law carries no general ester, isomer or derivative clause that would carry the entry across. Whether one of the ten decisions footnoted to article 19 names the ester separately cannot be established from the consolidated statute, which reproduces the decisions' dates and numbers but not their annexed lists.

Consequences if caught

Capital exposure: none. No article in this chain carries a capital or whole life route, and no per-substance threshold was verified for this row. If a classification decision names 4-AcO-DMT, the ceiling is 30 years under article 188(1) of Penal Code No. 5237, article 188(3) sets not less than ten years for domestic sale, supply, dispatch, transport, storage, purchase, acceptance and possession, and article 191(1) sets two to five years for possession for use with the five year deferral of 191(2) and at least a year of denetimli serbestlik under 191(3). If no decision names it, none of those provisions engages the ester as such. The metabolic relationship to psilocin does not convert one entry into the other for charging purposes, but a sample containing the scheduled compound is charged on the scheduled compound, and that is a laboratory question settled under article 20 of Law No. 2313.

If prescribed or medical

There is no prescription route for 4-AcO-DMT in Turkey and no medicinal preparation exists. The dossier carried no prescription instrument for this row and no per-substance medical route is asserted here. Article 188(6) of the Penal Code reaches substances whose production is permission bound or whose sale is prescription bound and which produce a narcotic or stimulant effect, and neither limb has been shown to apply to this ester. Research interest in related compounds abroad confers nothing at a Turkish border.

Documentation

Nothing documents an unconfirmed compound, and the specific problem here is that a synthesised ester and dried fungal material can produce the same reported analyte. Where the report names psilocin or psilocybin, the charge follows the scheduled substance and the origin of the material does not change it. A vendor label describing the product as a research chemical has no standing. The search log was read in the dossier on 18 September 2026 and article 19 of Law No. 2313 was read from the consolidated statute on 20 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Turkey’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.